Effect of Ru surface composition on the CO tolerance of Ru modified carbon supported Pt catalysts
文献情報
E. M. Crabb, M. K. Ravikumar, D. Thompsett, M. Hurford, A. Rose, A. E. Russell
A series of ruthenium modified carbon supported catalysts have been prepared by surface organometallic chemistry (SOMC) with the following nominal Ru∶Pt surface ratios, (1∶4)RuPt/C, (1∶2)RuPt/C, (3∶4)RuPt/C and (1∶1)RuPt/C. The catalysts were characterised using X-ray diffraction (XRD), extended X-ray absorption fine structure (EXAFS), cyclic voltammetry (CV), and half-cell polarisation studies. The XRD measurements showed that a bulk PtRu alloy was not formed following SOMC modification. However, the EXAFS measurements indicated that a surface alloy is formed upon electrochemical reduction of the Ru modified catalysts. The CV studies show that the electrooxidation of CO on the Ru modified Pt/C catalysts occurs at lower potentials than on the unmodified Pt/C catalysts, but at higher potentials than on an alloyed PtRu/C with a bulk composition of 1∶1 Pt∶Ru. Half cell polarisation measurements in 100 ppm CO in H2 show that the CO tolerance of the SOMC RuPt/C catalysts approached that of the conventional PtRu/C alloy catalyst. The results therefore indicate that a bulk alloy phase is not an essential factor in the improvement in CO tolerance of PtRu/C catalysts over that of Pt/C.
関連文献
Antibiotic administration in targeted nanoparticles protects the faecal microbiota of mice
Baris A. Borsa, Mert Sudagidan, Mehmet E. Aldag, Isik I. Baris, Elif E. Acar, Cagatay Acuner, Murat Kavruk, Veli C. Ozalp
DOI: 10.1039/D0MD00347F
Peptide-based delivery vectors with pre-defined geometrical locks
Ruchika Goyal, Gaurav Jerath, Aneesh Chandrasekharan, T. R. Santhosh Kumar, Vibin Ramakrishnan
DOI: 10.1039/D0MD00229A
Functionalized gold nanoparticles: promising and efficient diagnostic and therapeutic tools for HIV/AIDS
Shikha Gulati, Parinita Singh, Anchita Diwan, Ayush Mongia, Sanjay Kumar
DOI: 10.1039/D0MD00298D
4-Amino-1,8-naphthalimide–ferrocene conjugates as potential multi-targeted anticancer and fluorescent cellular imaging agents
Alex D. Johnson, Joseph A. Buhagiar, David C. Magri
DOI: 10.1039/D1MD00246E
2-Difluoromethylpyridine as a bioisosteric replacement of pyridine-N-oxide: the case of quorum sensing inhibitors
Thang Nguyen Quoc
DOI: 10.1039/D1MD00245G
Synthesis and σ receptor affinity of spiro[[2]benzopyran-1,1′-cyclohexanes] with an exocyclic amino moiety in the 3′-position
Elisabeth Kronenberg, Frauke Weber, Dirk Schepmann, Bernhard Wünsch
DOI: 10.1039/D0MD00307G
Hit-to-lead optimization of a benzene sulfonamide series for potential antileishmanial agents
Paul J. Koovits, Marco A. Dessoy, An Matheeussen, Louis Maes, Guy Caljon, Leonardo L. G. Ferreira, Rafael C. Chelucci, Simone Michelan-Duarte, Adriano D. Andricopulo, Simon Campbell, Jadel M. Kratz, Charles E. Mowbray, Luiz C. Dias
DOI: 10.1039/D0MD00165A
Towards a RIOK2 chemical probe: cellular potency improvement of a selective 2-(acylamino)pyridine series
Álvaro Lorente-Macías
DOI: 10.1039/D0MD00292E
こちらもおすすめ
2-ヒドロキシ-5-ニトロベンジンブロモイドの代替品はありますか?
2-ヒドロキシ-5-ニトロベンジンブロモイドは特定の化学反応に適しているため、代替品は限られています。しかし、同様の構造を持つ2-ヒドロキシ-4-ニトロベンジン...
N-(2-ブロモフェニル)-1-チロール-3-オキソ-3-(ピペリジニル)プロペン-2-イル)ベンゼンアミドを取り扱う際の実験室安全事項は何ですか?
N-(2-ブロモフェニル)-1-チロール-3-オキソ-3-(ピペリジニル)プロペン-2-イル)ベンゼンアミドは有毒で、皮膚や粘膜に刺激を与える可能性があります。...
1,3プロパンジオール,2-[2-(2アミノ-6クロロ-9Hピリミジン-9-イル)エチル-1,1,2,2-D4]-2,3-ジアセタートの市場動向や研究トレンドはどうですか?
この化合物は、新規治療薬の開発に注目されています。市場では、その有効性と安全性が評価され、研究分野では、分子生物学と医薬化学の新たな発見が期待されています。
Succinimidyl-alanyl-phenylalanyl-prolyl-phenylalanine 4-nitroanilide はどの業界で使用されていますか?
Succinimidyl-alanyl-phenylalanyl-prolyl-phenylalanine 4-nitroanilide は主に医薬品開発やポ...
メチル6-アミノ-5-クロロピリジン-2-カーボイル酸について、適用される法規ガイドラインは何ですか?
メチル6-アミノ-5-クロロピリジン-2-カーボイル酸(CAS番号: 1256794-05-4)の使用には、GHS( Globally Harmonized S...
エチル4-(シクロ Pentagonyl)アミノ-2-メチル硫化基ピリミジン-5-カルボキシレートを取り扱う際の実験室安全事項は何ですか?
取り扱いには、耐薬品性の容器を使用し、通気性の良い場所で操作することを推奨します。漏れ時は、SDS(安全データシート)を参照して適切な措置を取ること。手洗いと洗...
(S)-3-ベンZYルピペリジン塩酸塩とは何ですか?
(S)-3-ベンZYルピペリジン塩酸塩は、CAS番号1258940-00-9で表される化合物です。これは、(S)-3-苯基哌啶的盐酸盐であり、主に医薬品の原料と...
3,5-二甲基金剛胺の主な用途は何ですか?
3,5-二甲基金剛胺は、主に医薬品の原料として使用され、また抗うつ薬や抗アルツハイマー薬の開発に利用されます。さらに、化粧品や食品添加物の製造でも重要な役割を果...
ビス(4-メチル-2-ペンチル)フェニルカルボン酸エステルの代替品はありますか?
ビス(4-メチル-2-ペンチル)フェニルカルボン酸エステル (CAS番号: 1398066-13-1) の代替品には、ビス(2-エチルヘキシル)フェノールカルボ...
掲載誌
Physical Chemistry Chemical Physics

Physical Chemistry Chemical Physics (PCCP) is an international journal co-owned by 19 physical chemistry and physics societies from around the world. This journal publishes original, cutting-edge research in physical chemistry, chemical physics and biophysical chemistry. To be suitable for publication in PCCP, articles must include significant innovation and/or insight into physical chemistry; this is the most important criterion that reviewers and Editors will judge against when evaluating submissions. The journal has a broad scope and welcomes contributions spanning experiment, theory, computation and data science. Topical coverage includes spectroscopy, dynamics, kinetics, statistical mechanics, thermodynamics, electrochemistry, catalysis, surface science, quantum mechanics, quantum computing and machine learning. Interdisciplinary research areas such as polymers and soft matter, materials, nanoscience, energy, surfaces/interfaces, and biophysical chemistry are welcomed if they demonstrate significant innovation and/or insight into physical chemistry. Joined experimental/theoretical studies are particularly appreciated when complementary and based on up-to-date approaches.











![2,6-Bis({(2R)-2-[hydroxy(diphenyl)methyl]-1-pyrrolidinyl}methyl)-4-methylphenol structure 2,6-Bis({(2R)-2-[hydroxy(diphenyl)methyl]-1-pyrrolidinyl}methyl)-4-methylphenol structure](https://static.chemtradehub.com/structs/877/877395-58-9-70bf.webp)


